Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05764681 · ClinicalTrials.gov registry record

Chronic Postsurgical Pain

A clinical trial of Cerebral Palsy and Chronic Post Surgical Pain, sponsored by Chantel Burkitt.

Recruiting
Registry status
500
Enrollment target
2
Study locations

NCT05764681 is a study of Cerebral Palsy and Chronic Post Surgical Pain that is actively recruiting participants, run by Chantel Burkitt. The registered enrollment target is 500 participants, above the 224-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (123% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05764681, a study of Cerebral Palsy and Chronic Post Surgical Pain, is actively recruiting participants, sponsored by Chantel Burkitt.

RECRUITING
Registry status
500 participants
Enrollment target
2
Study locations

Study Summary

The study purpose is to document the typical trajectory of perioperative pain experience in Cerebral Palsy (CP) and to identify important predictive factors for the development of chronic postsurgical pain. The main aims of the investigators are to: 1. Quantify the trajectory of pain and opioid use in the context of orthopedic surgery in children with CP. 2. Identify predictors for CPSP in children with CP and develop an applicable risk index. 3. Examine relationships between perioperative pain severity and functional/mobility outcomes achieved by orthopedic surgery in children with CP. Participants will complete: 1. Questionnaires/Surveys via email and text message 2. In-person Sensory Tests 3. In-person Gait and Motion Analysis

Study Locations (2)

Delaware

  • Nemour's Children's Hospital - Wilmington

Minnesota

  • Gillette Children's Specialty Healthcare - Saint Paul

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-03-17
Est. Completion 2029-01

Sponsor

Chantel Burkitt

1 total trials

What the Registry Record Tells You About NCT05764681

The ClinicalTrials.gov registry entry for NCT05764681 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 224-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (123% higher). The listed sponsor is Chantel Burkitt, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 0 interventions.

NCT05764681 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Delaware, Minnesota.

Frequently Asked Questions

What is clinical trial NCT05764681 about?

NCT05764681 is a clinical study titled "Chronic Postsurgical Pain". The study purpose is to document the typical trajectory of perioperative pain experience in Cerebral Palsy (CP) and to identify important predictive factors for the development of chronic postsurgical pain. The main aims of the investigators are to: 1. Quantify the trajectory of pain and opioid use...

What is the current status of trial NCT05764681?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-03-17. Estimated completion is 2029-01.

What conditions does trial NCT05764681 study?

This clinical trial studies the following conditions: Cerebral Palsy, Chronic Post Surgical Pain.

Who is sponsoring clinical trial NCT05764681?

This trial is sponsored by Chantel Burkitt, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05764681 being conducted?

This trial has 2 study locations across Delaware, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.